Skip to content

Biopsychosocial model of inflammatory bowel diseases: The impact of multisystem comorbidity and mental health on patients' quality of life.

Aug 2026 · Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego · Vol 54 4, pp. 478-487 · 0 citations · 18 references
Medicine

Abstract

Objective

Aim: To determine the association between the presence of comorbid pathology, the frequency and nature of extraintestinal manifestations, and changes in different health-related quality-of-life domains in patients with inflammatory bowel diseases. PATIENTS AND

Methods

Materials and Methods: A total of 248 patients with inflammatory bowel disease were examined, including 117 with Crohn's disease (Group I) and 131 with ulcerative colitis (Group II). The control group consisted of 82 apparently healthy individuals. Patients received inpatient treatment at healthcare institutions in Ivano-Frankivsk. The diagnosis was established in accordance with current clinical guidelines. Quality of life was assessed using the IBDQ questionnaire, while comorbidity was evaluated using the Cumulative Illness Rating Scale (CIRS) and the Charlson Comorbidity Index.

Results

Results: Patients with IBD demonstrated a statistically significant decrease in the overall IBDQ quality-of-life index compared with the control group (119.3±10.48 in Crohn's disease and 127.4±8.3 in ulcerative colitis versus 198.5±12.6; p<0.001), corresponding to a reduction of 39.9% and 35.9%, respectively. The most pronounced impairments were observed in the systemic and social domains, particularly in patients with Crohn's disease. A high prevalence of comorbid pathology was identified (73% in Crohn's disease and 82% in ulcerative colitis), along with a substantial burden of extraintestinal manifestations, characterized by predominant multisystem involvement in Crohn's disease and mental and vascular disorders in ulcerative colitis. The Charlson Comorbidity Index was higher in Crohn's disease (3.14±0.27) compared with ulcerative colitis (2.93±0.14; p≤0.005), indicating a less favorable prognosis in this patient group.

Conclusion

Conclusions: Inflammatory bowel diseases are associated with a marked deterioration in quality of life and a high comorbid burden, substantiating the need for a comprehensive multidisciplinary approach to the management of such patients.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.